Myopia Profile

Eyerising Myopia Management Device

The Eyerising myopia management device uses proprietary technology for administering Repeated Low-Level Red-Light (RLRL) therapy that enhances blood circulation in the ocular fundus, addressing sclera hypoxia and managing the axial elongation associated with myopia. It is backed by 2-year clinical trial results showing myopia control efficacy, and complies with Australian Standard IEC 60825-1:2014 for laser products safety. 

Visit the Eyerising Myopia Management Device website.

Instrument
Eyerising International
Eyerising Myopia Management Device
Myopia control device that delivers repeated low-level red-light (RLRL) to the ocular fundus.
Securely shares patient compliance data with practitioners to monitor efficacy and safe use
Instruments

Eyerising Myopia Management Device articles in Myopia Profile

Enormous thanks to our visionary sponsors

Myopia Profile’s growth into a world leading platform has been made possible through the support of our visionary sponsors, who share our mission to improve children’s vision care worldwide. Click on their logos to learn about how these companies are innovating and developing resources with us to support you in managing your patients with myopia.